(Q37972825)

26 August 2017

title

Pharmacologic strategies to target oxidative stress in heart failure (English)

1 reference

26 August 2017

0 references

1 reference

Zain Ahmed

1

1 reference

26 August 2017

W H Wilson Tang

series ordinal

2

1 reference

26 August 2017

publication date

1 March 2012

1 reference

Current heart failure reports

26 August 2017

published in

1 reference

26 August 2017

volume

9

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

14-22

1 reference

Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Aging: a theory based on free radical and radiation chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Reactive oxygen species in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Role of oxygen free radicals in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Provision of cardiovascular protection by ACE inhibitors: a review of recent trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Structure and function of xanthine oxidoreductase: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

The neutrophil NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Chronic granulomatous disease: a review of the infectious and inflammatory complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

NOX enzymes and the biology of reactive oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

The superoxide-generating NADPH oxidase: structural aspects and activation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Requirement of Rac1 in the development of cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

The Rac and Rho hall of fame: a decade of hypertrophic signaling hits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Mitochondrial reactive oxygen species drive proinflammatory cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Nitrosative stress leads to protein glutathiolation, increased s-nitrosation, and up-regulation of peroxiredoxins in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Nitrosative stress and pharmacological modulation of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Myeloperoxidase, a leukocyte-derived vascular NO oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Nitric oxide is a physiological substrate for mammalian peroxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Pharmacological effects and clinical applications of propionyl-L-carnitine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Vitamin C and risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Antioxidant treatment for heart failure: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Is there any hope for vitamin E?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Xanthine oxidase inhibitors the unappreciated treatment for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Allopurinol and global left myocardial function in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Omega-3 polyunsaturated fatty acids and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Polyunsaturated fatty acids in heart failure: should we give more and give earlier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Oxidative stress and mitochondrial DNA damage in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

The ongoing search for a stratified medicine approach in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Enhanced Expression and Activity of Xanthine Oxidoreductase in the Failing Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0081-5

Vitamin C intake and mortality among a sample of the United States population.

21 January 2018

1 reference

12 December 2020

Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy

1 reference

12 December 2020

Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning

1 reference

12 December 2020

Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study

1 reference

12 December 2020

Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling

1 reference

12 December 2020

Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies

1 reference

12 December 2020

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

1 reference

12 December 2020

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

12 December 2020

The role of oxidative stress in the metabolic syndrome.

1 reference

12 December 2020

Marine polyunsaturated fatty acids in heart failure. Are the theoretical benefits matched by the clinical data?

1 reference

12 December 2020

Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress

1 reference

12 December 2020

Oxygen, oxidative stress, hypoxia, and heart failure

1 reference

12 December 2020

Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure

1 reference

12 December 2020

Signal transduction by reactive oxygen species in non-phagocytic cells.

1 reference

12 December 2020

Oxidative stress causes heart failure with impaired mitochondrial respiration

1 reference

12 December 2020

Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure

1 reference

12 December 2020

Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis

1 reference

12 December 2020

10.1007/S11897-011-0081-5

Identifiers

DOI

1 reference

26 August 2017

1 reference